• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, September 5, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Smokers who undergo a CT scan of their lungs more likely to quit

Bioengineer by Bioengineer
July 26, 2017
in Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

New research published in the scientific journal Thorax has found that smokers who undergo a CT scan of their lungs are more likely to quit smoking.

Lung cancer is one of the most common and serious types of cancer and has the highest mortality of all cancers in the UK. Around 44,500 people are diagnosed with the condition every year in the UK.

The smoking cessation analysis of the UKLS trial, was led by researchers at Cardiff University working with the University of Liverpool's Institute of Translational Medicine, King's College London and Queen Mary University of London, involved 4,055 participants aged 50 to 75.

15% per cent success rate

The group was split into those who underwent low-dose CT screening for early detection of lung cancer and a control group who did not undergo screening.

Of the smokers who took part in the screening, 10 per cent had successfully quit after two weeks, and 15 per cent had quit after two years — both higher than the 5% rates found in the control group.

The UK Lung Cancer Screening pilot trial is the first to assess the feasibility, cost-effectiveness and behavioural impact of lung cancer screening, using a single low-dose CT screen on a high-risk population in the UK.

Licence to smoke

Professor John Field, University of Liverpool's Clinical Professor of Molecular Oncology, Chief Investigator of the UK Lung Cancer Screening Trial and Principal Investigator of the Liverpool Lung Project, said: "Lung cancer continues to be the leading cause of cancer mortality worldwide.

"The findings of this study dispute the belief that a negative screening result offers a "licence to smoke". Engaging with lung screening can give smokers an opportunity to access smoking cessation support — at a time when they are likely to be more receptive to offers of help."

Dr Kate Brain, from Cardiff University, said: "Our trial shows that CT lung cancer screening offers a teachable moment for smoking cessation among high-risk groups in the UK.

"We now need evidence about the best ways of integrating lung cancer screening with stop-smoking support, so that services are designed to deliver the maximum health benefits for current and future generations."

The full study, entitled 'Impact of low-dose CT screening on smoking cessation among high-risk participants in the UK Lung Cancer Screening Trial', can be found here http://thorax.bmj.com/content/early/2017/07/14/thoraxjnl-2016-209690

###

Media Contact

Simon Wood
[email protected]
44-151-794-8356
@livuninews

http://www.liv.ac.uk

http://dx.doi.org/10.1136/thoraxjnl-2016-209690

Share12Tweet7Share2ShareShareShare1

Related Posts

Viral Mimicry and Mitochondrial Signals Fuel Cancer

September 5, 2025

Gestational Diabetes Thresholds Impact Infant Growth, Development

September 5, 2025

ACE2 Decoy Receptor Battles Mutant SARS-CoV-2 Variants

September 5, 2025

COVID-19 Disruption Accelerates Chronic Kidney Disease Progression

September 5, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    149 shares
    Share 60 Tweet 37
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    142 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    115 shares
    Share 46 Tweet 29
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    61 shares
    Share 24 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Viral Mimicry and Mitochondrial Signals Fuel Cancer

Gestational Diabetes Thresholds Impact Infant Growth, Development

ACE2 Decoy Receptor Battles Mutant SARS-CoV-2 Variants

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.